198 related articles for article (PubMed ID: 26368941)
1. Refractory bipolar disorder and neuroprogression.
da Costa SC; Passos IC; Lowri C; Soares JC; Kapczinski F
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Oct; 70():103-10. PubMed ID: 26368941
[TBL] [Abstract][Full Text] [Related]
2. Neuroprogression and illness trajectories in bipolar disorder.
Kapczinski NS; Mwangi B; Cassidy RM; Librenza-Garcia D; Bermudez MB; Kauer-Sant'anna M; Kapczinski F; Passos IC
Expert Rev Neurother; 2017 Mar; 17(3):277-285. PubMed ID: 27659841
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance takes center stage: a new paradigm in the progression of bipolar disorder.
Calkin CV
Ann Med; 2019; 51(5-6):281-293. PubMed ID: 31453713
[TBL] [Abstract][Full Text] [Related]
4. Stage managing bipolar disorder.
Berk M; Berk L; Dodd S; Cotton S; Macneil C; Daglas R; Conus P; Bechdolf A; Moylan S; Malhi GS
Bipolar Disord; 2014 Aug; 16(5):471-7. PubMed ID: 23782499
[TBL] [Abstract][Full Text] [Related]
5. Areas of controversy in neuroprogression in bipolar disorder.
Passos IC; Mwangi B; Vieta E; Berk M; Kapczinski F
Acta Psychiatr Scand; 2016 Aug; 134(2):91-103. PubMed ID: 27097559
[TBL] [Abstract][Full Text] [Related]
6. Staging and neuroprogression in bipolar disorder: a systematic review of the literature.
Gama CS; Kunz M; Magalhães PV; Kapczinski F
Braz J Psychiatry; 2013 Mar; 35(1):70-4. PubMed ID: 23567604
[TBL] [Abstract][Full Text] [Related]
7. The theory of bipolar disorder as an illness of accelerated aging: implications for clinical care and research.
Rizzo LB; Costa LG; Mansur RB; Swardfager W; Belangero SI; Grassi-Oliveira R; McIntyre RS; Bauer ME; Brietzke E
Neurosci Biobehav Rev; 2014 May; 42():157-69. PubMed ID: 24548785
[TBL] [Abstract][Full Text] [Related]
8. Inflammation as a Mechanism of Bipolar Disorder Neuroprogression.
Barichello T; Giridharan VV; Bhatti G; Sayana P; Doifode T; Macedo D; Quevedo J
Curr Top Behav Neurosci; 2021; 48():215-237. PubMed ID: 33040314
[TBL] [Abstract][Full Text] [Related]
9. A critical overview of the clinical evidence supporting the concept of neuroprogression in bipolar disorder.
Martino DJ; Samamé C; Marengo E; Igoa A; Strejilevich SA
Psychiatry Res; 2016 Jan; 235():1-6. PubMed ID: 26723135
[No Abstract] [Full Text] [Related]
10. Overlapping mechanisms linking insulin resistance with cognition and neuroprogression in bipolar disorder.
Cuperfain AB; Kennedy JL; Gonçalves VF
Neurosci Biobehav Rev; 2020 Apr; 111():125-134. PubMed ID: 31978440
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory Markers in the Staging of Bipolar Disorder: A Systematic Review of the Literature.
Castaño-Ramírez OM; Sepúlveda-Arias JC; Duica K; Díaz Zuluaga AM; Vargas C; López-Jaramillo C
Rev Colomb Psiquiatr (Engl Ed); 2018; 47(2):119-128. PubMed ID: 29754705
[TBL] [Abstract][Full Text] [Related]
12. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors.
Berk M; Kapczinski F; Andreazza AC; Dean OM; Giorlando F; Maes M; Yücel M; Gama CS; Dodd S; Dean B; Magalhães PV; Amminger P; McGorry P; Malhi GS
Neurosci Biobehav Rev; 2011 Jan; 35(3):804-17. PubMed ID: 20934453
[TBL] [Abstract][Full Text] [Related]
13. [Bipolar disorder: staging and neuroprogression].
Rodrigues AA; Rosa AR; Kunz M; Bruna A; Kapczinski F
Psychiatr Pol; 2014; 48(2):231-43. PubMed ID: 25016762
[TBL] [Abstract][Full Text] [Related]
14. The Link between Refractoriness and Neuroprogression in Treatment-Resistant Bipolar Disorder.
Bauer IE; Soares JC; Selek S; Meyer TD
Mod Trends Pharmacopsychiatry; 2017; 31():10-26. PubMed ID: 28738324
[TBL] [Abstract][Full Text] [Related]
15. Neuroprogression in bipolar disorder.
Schneider MR; DelBello MP; McNamara RK; Strakowski SM; Adler CM
Bipolar Disord; 2012 Jun; 14(4):356-74. PubMed ID: 22631620
[TBL] [Abstract][Full Text] [Related]
16. Staging and neuroprogression in bipolar disorder.
Fries GR; Pfaffenseller B; Stertz L; Paz AV; Dargél AA; Kunz M; Kapczinski F
Curr Psychiatry Rep; 2012 Dec; 14(6):667-75. PubMed ID: 23090632
[TBL] [Abstract][Full Text] [Related]
17. Bipolar disorder: multiple pathways to neuroprogression.
Nierenberg AA
Acta Psychiatr Scand; 2016 Aug; 134(2):89-90. PubMed ID: 27384497
[No Abstract] [Full Text] [Related]
18. Neuron-glia Interaction as a Possible Pathophysiological Mechanism of Bipolar Disorder.
Pinto JV; Passos IC; Librenza-Garcia D; Marcon G; Schneider MA; Conte JH; da Silva JPA; Lima LP; Quincozes-Santos A; Kauer-Sant Anna M; Kapczinski F
Curr Neuropharmacol; 2018; 16(5):519-532. PubMed ID: 28847296
[TBL] [Abstract][Full Text] [Related]
19. Mediators of allostasis and systemic toxicity in bipolar disorder.
Grande I; Magalhães PV; Kunz M; Vieta E; Kapczinski F
Physiol Behav; 2012 Apr; 106(1):46-50. PubMed ID: 22079584
[TBL] [Abstract][Full Text] [Related]
20. Evidence and implications for early intervention in bipolar disorder.
Berk M; Hallam K; Malhi GS; Henry L; Hasty M; Macneil C; Yucel M; Pantelis C; Murphy B; Vieta E; Dodd S; McGorry PD
J Ment Health; 2010 Apr; 19(2):113-26. PubMed ID: 20433320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
